CEP (+) patients | CEP (−) patients | p-value | |
---|---|---|---|
Patients, n | 18 | 9 | |
BNP, pg/ml | 241 [22–925] | 62 [36–435] | 0.19 |
6MWT distance, m | 358.8 ± 97.2 | 443.6 ± 95.4 | 0.06 |
SUVRV/SUVLV ratio | 1.29 ± 0.78 | 0.51 ± 0.39 | 0.003 |
RVEF, % | 40.9 ± 8.8 | 52.5 ± 8.4 | 0.004 |
TAPSE, mm | 17.9 ± 4.0 | 21.3 ± 4.2 | 0.07 |
PAC, ml/mmHg | 2.0 ± 0.9 | 3.3 ± 2.3 | 0.06 |
mPAP, mmHg | 56.3 ± 15.8 | 33.1 ± 8.2 | < 0.001 |
PVR, wood units | 10.9 ± 5.3 | 4.3 ± 2.3 | < 0.001 |
RV GLS, % | − 13.5 ± 7 | − 22.2 ± 3.8 | 0.001 |
RV GLS/PASP, %/mmHg | − 0.16 ± 0.08 | − 0.44 ± 0.11 | < 0.001 |
RV GLS/PVR, %/WU | − 1.75 ± 1.68 | − 6.4 ± 3.1 | < 0.001 |
RVGLS*PAC, %*mmHg/ml | − 26 ± 16.7 | − 75.1 ± 54.3 | < 0.001 |
RVEF/PASP, %*mmHg | 0.51 ± 0.21 | 1.02 ± 0.36 | < 0.001 |
RVEF/PVR, %*WU | 5.37 ± 4.16 | 15.72 ± 8.26 | < 0.001 |
RVEF*PAC, %/mmHg/ml | 85.3 ± 50.4 | 181.9 ± 133.1 | 0.006 |
TAPSE/RVSP (echo/echo) | 0.30 ± 0.17 | 0.44 ± 0.21 | 0.012 |
TAPSE/RVSP (CMR/echo) | 0.28 ± 0.16 | 0.55 ± 0.21 | 0.03 |
RV GLS/RVSP (CMR/echo) | − 0.22 ± 0.19 | − 0.57 ± 0.21 | 0.03 |
RVEF/RVSP (CMR/echo) | 0.68 ± 0.39 | 1.26 ± 0.58 | 0.01 |